Skip to content
DataLookout
Menu

NCT06208137

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

StatusTerminated
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: Insufficient execution and compliance Show 4 more changesShow less
    • Eligibility criteria expanded, about 6 words
    • Final enrollment: 150 participants (planned 456)
    • Primary completion date changed from estimate of Oct 1, 2027 to Jan 1, 2026
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2024 to Feb 29, 2024
    • Site details revised
    v3
  3. Notable Enrollment target: 1000 to 456v2 Show 5 more changesShow less
    • Start date: Feb 2024 to Apr 1, 2024
    • Eligibility criteria expanded, about 1 word
    • Primary completion date: Feb 2028 to Oct 1, 2027
    • Study completion date: Jul 2028 to Apr 1, 2028
    • Secondary endpoints: details revised at 3 of 3 entries
  4. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Survival
Timeframe: 1.5 years after transplantation

Secondary (3)

Non-relapse mortality rate
Incidence of infections
Immune cell count

Arms and interventions

Intervention groupExperimental

Remind patients to test their immune status among 120-180 days post-transplantation. Physicians assessed the risk level of patients in the intervention group based on their immune status on days 91-180 using the CIRS.

Control groupNo intervention

Only remind patients to test their immune status among 120-180 days post-transplantation.

Behavioral: Health monitoring and regular return follow-up reminders

Sites

1 site in 1 country

  • Institute of Hematology & Blood Diseases HospitalTianjin, Tianjin Municipality, China